Samar Al-Emadi

Samar Al Emadi

Senior Consultant Rheumatologist
Head of Rheumatology Division
Medicine Department
Rheumatology Fellowship Program Director
Hamad Medical Corporation
London Business School

Dr. Samar Al-Emadi is a Senior Consultant Rheumatologist, Head of Rheumatology Division at Hamad Medical Corporation. She is also a Fellowship Program Director in Rheumatology, Hamad Medical Corporation. an Assistant Professor at Weill Cornell Medical College in Qatar and is a faculty member for Clinical Teaching Program in Hamad Medical Corporation and Weill Cornell Medical College in Qatar, and Stanford Faculty Development Center for Clinical Teachers.

Dr. Al-Emadi received her medical degree from the King Abdul Aziz University in Jeddah, KSA in 1995. Double board certified in Internal Medicine (American board of Internal Medicine and Royal College of Physician and Surgeon of Canada) also double board certified in Rheumatology from American College of Rheumatology and Royal College of Physician Canada 2005. She has also completed Executive Master of Business Administration degree from London Business School (London -UK-LBS) 2018.

She’s had special interest in Pregnancy and Rheumatic disease, where she had extended her fellowship in Toronto with Prof Karl Laskin. Dr. Samar has established the first structured pregnancy and rheumatic disease clinic in Hamad General Hospital. Qatar.

Currently, Dr. Samar Al-Emadi is a member of multiple corporate committees, member of the Governance and Strategy of Hamad Medical Corporation Research Committee, and Steering Committee for OPD Development. She is also a member of multiple committees locally and regionally, multiple advisory boards.

Dr. Samar has received multiple research grants. She already has several publications in peer reviewed journals and is also involved in multiple RCT as a PI and Co-PI.

She is a speaker in multiple local and regional conferences. She has also received several awards such as Best Team Research Award 2015 and recently Chairman Recognition Award 2018.